Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-03-30 | D. Gary Gilliland 63 2014 President and Director of the NCI-designated Fred Hutchinson Cancer Research Center in Seattle, WA Independent Director Audit Committee |
| 2019-03-29 | D. Gary Gilliland has served as a director of the Company since April 1, 2014. Since January 2, 2015, Dr. Gilliland has served as President and Director of the NCI designated Fred Hutchinson Cancer Research Center in Seattle, WA. Dr. Gilliland also brings to the board executive experience in clinical research, as well as in healthcare finance and mergers and acquisitions. |
| 2020-04-01 | D. Gary Gilliland has served as a director of the Company since April 1, 2014. ... Members of the Audit Committee include Dr. Gilliland. ... Members of the Quality and Compliance Committee include Dr. Gilliland. ... The compensation paid by the Company to the non-employee directors for 2019 is set forth in the table below. ... D. Gary Gilliland: Fees Earned or Paid in Cash $110,000, Restricted Stock Unit Awards $179,866, Total $289,866. |
| 2021-04-02 | D. Gary Gilliland has served as a director of the Company since April 1, 2014. Dr. Gilliland has served as President and Director Emeritus of the Fred Hutchinson Cancer Research Center, a research organization, in Seattle, WA since January 31, 2020. Audit Committee, Quality and Compliance Committee |
| 2022-03-31 | D. Gary Gilliland has served as a director of the Company since April 1, 2014. Dr. Gilliland has served as President and Director Emeritus of the Fred Hutchinson Cancer Research Center, a research organization, in Seattle, WA since January 31, 2020. Dr. Gilliland serves on the Audit Committee and the Quality and Compliance Committee. |
| 2023-03-30 | D. Gary Gilliland has served as a director of the Company since April 1, 2014. Dr. Gilliland has served as President and Director Emeritus of the Fred Hutchinson Cancer Research Center, a research organization, in Seattle, WA since January 31, 2020. |
Data sourced from SEC filings. Last updated: 2026-02-03